Ablation of TNF or lymphotoxin signaling and the frequency of spontaneous tumors in p53-deficient mice

被引：14

作者：

Kuprash, Dmitry V. ^{[1
]}

Qin, Zhihai ^{[1
,7
]}

Ito, Daisuke ^{[3
,4
]}

Grivennikov, Sergei I. ^{[1
,3
,4
]}

Abe, Koichiro ^{[3
,4
]}

Drutskaya, Ludmila N. ^{[3
,4
]}

Blankenstein, Thomas ^{[2
,5
]}

Nedospasov, Sergel A. ^{[1
,6
]}

机构：

[1] Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow 119991, Russia

[2] Charite, Inst Immunol, D-12200 Berlin, Germany

[3] NCI, Mol Immunoregulat Lab, Ctr Canc Res, Frederick, MD 21702 USA

[4] NCI, Basic Res Lab, Ctr Canc Res, Frederick, MD 21702 USA

[5] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany

[6] German Rheumatism Res Ctr DRFZ, D-10117 Berlin, Germany

[7] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China

来源：

CANCER LETTERS | 2008年 / 268卷 / 01期

基金：

美国国家卫生研究院;

关键词：

cytokine and chemokine biology; p53/mdm2; tumor immunology; knockout mice;

D O I：

10.1016/j.canlet.2008.03.023

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TNF plays diverse and contrasting roles in cancer, promoting skin carcinogenesis and metastasis, but also possessing potent antitumor effects in mice. TNF via TNFR1 axis induces NF kappa B, and may contribute to inflammation-facilitated neoplasia. On the other hand, lymphomas are cited as rare complications of anti-TNF therapy in humans. In order to address possible modulating role of TNF and of a related cytokine, LT alpha, in spontaneous tumorigenesis, we compared mice with p53-TNF, p53-LT alpha, p53-TNFR1 and p53-TNF-LT combined deficiencies. Unexpectedly, neither of these mice showed significant modulation of their survival or shift in the spectrum of emerging tumors, as compared to p53-deficient mice, arguing against direct link between TNF blockade and lymphoma development. (C) 2008 Elsevier Ireland Ltd. All rights reserved.

引用

页码：70 / 75

页数：6

共 50 条

[41] Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen- and tissue-dependent
French, JE
Lacks, GD
Trempus, C
Dunnick, JK
Foley, J
Mahler, J
Tice, RR
Tennant, RW
CARCINOGENESIS, 2001, 22 (01) : 99 - 106
[42] TPRKB dependency in p53-deficient cancers
VanDenBerg, Kelly
Goswami, Moloy
Wang, Lei Lucy
Singh, Bhavneet
Weiss, Travis
Han, Sumin
Rhodes, Dan
Feng, Felix
Tomlins, Scott
CANCER RESEARCH, 2017, 77
[43] ENHANCED PROLIFERATIVE POTENTIAL IN CULTURE OF CELLS FROM P53-DEFICIENT MICE
TSUKADA, T
TOMOOKA, Y
TAKAI, S
UEDA, Y
NISHIKAWA, S
YAGI, T
TOKUNAGA, T
TAKEDA, N
SUDA, Y
ABE, S
MATSUO, I
IKAWA, Y
AIZAWA, S
ONCOGENE, 1993, 8 (12) : 3313 - 3322
[44] P53-DEFICIENT MICE ARE EXTREMELY SUSCEPTIBLE TO RADIATION-INDUCED TUMORIGENESIS
KEMP, CJ
WHELDON, T
BALMAIN, A
NATURE GENETICS, 1994, 8 (01) : 66 - 69
[45] Analysis of fused maxillary incisor dentition in p53-deficient exencephalic mice
Kaufman, MH
Kaufman, DB
Brune, RM
Stark, M
Armstrong, JF
Clarke, AR
JOURNAL OF ANATOMY, 1997, 191 : 57 - 64
[46] Altered growth response of oral mucosal keratinocytes in p53-deficient mice
Ito, D
Kamijo, R
Nakanishi, Y
Toyoshima, T
Takizawa, K
Sumitani, K
Nagumo, M
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1999, 28 (08) : 371 - 376
[47] Susceptibility of p53-deficient mice to induction of mesothelioma by crocidolite asbestos fibers
Marsella, JM
Liu, BL
Vaslet, CA
Kane, AB
ENVIRONMENTAL HEALTH PERSPECTIVES, 1997, 105 : 1069 - 1072
[48] P53-deficient mice are protected against adrenalectomy-induced apoptosis
Sakhi, S
Gilmore, W
Tran, ND
Schreiber, SS
NEUROREPORT, 1996, 8 (01) : 233 - 235
[49] Loss of the aryl hydrocarbon receptor increases tumorigenesis in p53-deficient mice
Phillips, Jessica L.
Loehr, Christiane, V
Nguyen, Bach D.
Buermeyer, Andrew B.
Kolluri, Siva K.
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2022, 454
[50] Cell lines established from fetal brains of p53-deficient mice
Tomooka, Y
Aizawa, S
CELL STRUCTURE AND FUNCTION, 1998, 23 (02) : 101 - 107

← 1 2 3 4 5 →